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Abstract 16 
New psychoactive substances (NPS) have increased in use and popularity worldwide. 17 
Wastewater analysis has been successfully applied to evaluate illicit drugs use within a 18 
population. However, for NPS, such approach may be limited due to low doses of NPS 19 
combined with their ever-changing composition and usage. The dynamic nature of the NPS 20 
market means use may be opportunistic, infrequent and with few users. Hence, the use of 21 
complementary information sources is recommended to improve the knowledge on NPS 22 
consumption. The aim of this study was to investigate the changing landscape of NPS use on 23 
a community scale by combining wastewater analysis and forensic toxicology. Forensic 24 
analysis provided specific information on NPS prevalence in post-mortem blood samples in 25 
Adelaide, South Australia over five years, while wastewater analysis showed community use 26 
over the same period. A qualitative liquid chromatography-high resolution mass spectrometry 27 
method was initially used to screen the wastewater samples. A total of 24 NPS were found: 28 
six in wastewater only, 13 in forensic post mortem toxicology samples only and five in both. 29 
As these results showed the presence of NPS, a targeted method was subsequently employed 30 
to quantify levels of these NPS in wastewater. Temporal trends were found in wastewater 31 
with distinct tendencies for synthetic cathinones visible over the period studied.  32 
 33 
Keywords: Synthetic cathinones, High resolution mass spectrometry, Triple quadrupole, 34 
Wastewater, Forensic toxicology  35 
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1. Introduction 36 
The use of new psychoactive substances (NPS) is an area of worldwide concern, with NPS 37 
gaining popularity, sometimes in place of more conventional illicit drugs. 
1
 In Europe alone, 38 
more than 670 such compounds have been reported to date, with this number growing every 39 
year as producers and sellers attempt to avoid legislation. 
2,3
 Existing means to monitor NPS 40 
use and exposure include drug seizures, police intelligence, media, surveys, forensic 41 
toxicology reports and hospital admissions.  Nationwide seizure data can provide information 42 
on the most prevalent drugs entering the country or particular cities, but the effects on the 43 
drug-taking community of any large seizures could take months to be seen. Furthermore, 44 
effects may not be evident at a local level. Surveys may not reflect actual use due to 45 
unwitting consumption of adulterated drugs. On a community level, roadside drug testing and 46 
population surveys predominantly inform on the most common drugs such as MDMA, 47 
cannabis, methamphetamine and alcohol. 
4,5
 However, both have their own bias in terms of 48 
“targeted policing” sampling and reporting. 5,6  Mechanisms to report hospital admissions and 49 
forensic toxicology findings may not be publicly available. Wastewater analysis (WWA) has 50 
thus been proposed as a suitable complementary means to provide temporal and spatial trends 51 
in NPS use, because it can give information on the identity and amount of drugs being used at 52 
any given time. 
7,8
  53 
The ever-changing nature of the NPS market means acquiring standards and developing 54 
quantitative analytical methods for compounds which may have a short commercial lifetime 55 
is unfeasible. Therefore, targeted, quantitative wastewater methods have limitations, due to 56 
the time and expense involved in acquiring standards and developing methods for compounds 57 
which may not have an extended lifetime. In this regard, there has been a shift toward 58 
qualitative, suspect compound screening methodologies using liquid chromatography coupled 59 
to high resolution mass spectrometry (LC-HRMS).  These do not initially require standards 60 
and the range of compounds that can be analysed is limited only by the suspect screening 61 
database. 
9–13
  62 
The drawback of qualitative screening based on HRMS is its inherent lower sensitivity 63 
compared to targeted quantitative methods, e.g. based on LC-MS/MS with triple quadrupole 64 
(QqQ). In contrast to popular, conventional, illicit drugs, the use of NPS at any particular 65 
time is generally low. Added to that, the low doses and extensive metabolism of some NPS 66 
mean that excreted levels of drug residues in wastewater may be very low. Furthermore, their 67 
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detection by LC-HRMS could be affected by the complexity of the matrix. Thus, targeted, 68 
quantitative methods still have value, although they are limited to the target list of 69 
compounds included in the scope of the method, with the corresponding reference standards 70 
being required for method optimization, data acquisition  and quantification 
14–19
 71 
In the forensic context, biological samples may be taken from members of the public for drug 72 
testing as part of investigations into traffic offences assaults and other criminal activity. 73 
Blood samples are taken routinely in post-mortem examinations. Therefore, forensic 74 
toxicology can be considered a frontline in the detection of the latest NPS. Toxicological 75 
analysis of post mortem cases can demonstrate the presence of particularly harmful 76 
substances in the community. The concentration of some NPS in acute intoxications may be 77 
relatively high, which may facilitate identification of hitherto unknown intoxicants through 78 
generation of molecular formula and interpretation of spectral information. However, in 79 
contrast to wastewater, forensic data is unlikely to be able to show changing temporal 80 
patterns of use. Thus, the comparison of forensic data with the results of WWA enables a 81 
better informed and targeted approach to investigate both which NPS are being used and the 82 
temporal changes in their NPS.  83 
Our group has been analysing wastewater samples from South Australia since 2009, 84 
primarily to quantify conventional illicit drugs. 
20–22
 Until this study, only the most popular 85 
NPS were included in the method due to difficulties in the selection of target compounds 86 
from the wide range of possible NPS candidates. In the present work, data from the analysis 87 
of 156 wastewater and over 3,500 forensic samples were combined to show the NPS 88 
prevalence in Adelaide, South Australia over a 5 year period. The aim of this study was to 89 
investigate the use of NPS on a community scale by combining wastewater analysis and 90 
forensic toxicology. The forensic data comprised the results of post-mortem investigations 91 
from Forensic Science South Australia (FSSA) in known or suspected drug related deaths 92 
over the period. After identification of NPS in wastewater by HRMS using a database of 186 93 
compounds, quantitative analysis of those NPS identified in the samples was performed.   94 
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2. Materials and Methods 95 
2.1 Chemicals and Reagents 96 
A total of 85 NPS reference standards in the form of mixed standard solutions in methanol 97 
were made available for use by Forensic Science SA (FSSA) for the screening method (Table 98 
S1). The mixed solutions were supplied in accordance with the appropriate licencing 99 
conditions at both the FSSA and the University of South Australia sites. Butylone, 100 
mephedrone, methylenedioxypyrovalerone (MDPV), methedrone, methylone, naphyrone and 101 
N-ethylcathinone were analysed quantitatively as in our previous work 
19
, with pentylone, 102 
ethylone, alpha-pyrrolidinopentiophenone (alpha-PVP), methcathinone, dimethylone, 103 
methoxetamine, 4-methylethcathinone, β-pentedrone, N,N-dimethylcathinone, 4-104 
fluoromethcathinone, 3,4-dimethylmethcathinone, buphedrone and 1,3-benzodioxolyl-N-105 
methylbutanamine (MBDB) additionally analysed. Only methylone-d3
 
and MDPV-d8 were 106 
added as internal standards as the deuterated analogues for all of the above NPS were not 107 
available at the time of the study.  The standards and deuterated analogues were purchased 108 
from Cerilliant (Round Rock, TX, USA) and Cayman Chemicals (Ann Arbor, MI, USA).  109 
Reagents for the work performed at the University of South Australia: Glacial acetic acid, 110 
sodium acetate, isopropanol, ammonia (28 %) and formic acid (99 %) were purchased from 111 
VWR Chemicals (Tingalpa, Queensland, Australia), while methanol, hydrochloric acid (37 112 
%) and dichloromethane were purchased from Merck (Kilsyth, VIC, Australia), and sodium 113 
metabisulfate (Na2S2O5) from Chem-Supply (Gillman, SA, Australia) Ultrapure water was 114 
prepared using an Arium® pro VF system (Sartorius Stedim biotech).   115 
Reagents for the analysis performed at University Jaume I: HPLC-grade methanol, 116 
ammonium acetate, ammonia solution (25 %) and formic acid ( 98–100 %) were acquired 117 
from Scharlau (Barcelona, Spain). HPLC-grade water was obtained by purifying 118 
demineralised water in a Milli-Q plus system from Millipore (Bedford, MA, USA). 119 
2.2 Samples 120 
2.2.1 Wastewater samples 121 
24-h (8 a.m.–8 a.m.) flow proportional composite influent wastewater (IWW)  was collected 122 
bimonthly during the first week of February, April, June, August, October, December (or the 123 
second week to avoid public holidays) from June 2012 – June 2017 from two wastewater 124 
treatment plants (WWTPs) in South Australia. Samples from the two sites investigated, 125 
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hereafter called Site A (covering approximately 700,000 inhabitants) and Site B (covering 126 
approximately 200,000 inhabitants), corresponded to at least one weekend sample (Saturday 127 
or Sunday) and one weekday (Monday – Friday) sample. A total of 156 samples were 128 
analysed for this study. South Australia has a population of approximately 1.6 million 129 
inhabitants, so these two sites cover approximately 75% of the state. Specific information on 130 
sample collection was reported previously. 
20
 131 
Immediately after collection, samples were stored at 4 °C in 2 g/L Na2S2O5 for up to one 132 
week prior to sample preparation. Sample extracts were stored at -20°C, prior to analysis. 133 
A selection of the extracted samples, covering five time periods from February 2015 – 134 
August 2017 were sent to the University Jaume I, Castellon (Spain) for the quantitative 135 
analysis of various NPS. 136 
2.2.2 Forensic samples 137 
The Toxicology Group at Forensic Science SA conducts forensic examinations on biological 138 
samples at the direction of the South Australian State Coroner, South Australia Police, and 139 
other agencies. Approximately 900 South Australian post mortem toxicology cases are 140 
analysed annually for a range of pharmaceutical and illicit substances on behalf of the South 141 
Australian Coroner. All post mortem toxicology cases between August 2013 and June 2017. 142 
Those in which one or more NPS were detected through the routine toxicological screening 143 
methodology are included in this dataset (Table S2). Peripheral blood samples (femoral) 144 
were the typical sample specimen type used for drug screening. Hospital ante-mortem or 145 
other blood or tissue specimens may also have been examined as specific case circumstances 146 
dictated. Permission was obtained from the South Australian Coroner to use de-identified 147 
data relating to NPS detections in this dataset. The case types include those where the cause 148 
of death was not drug related, as well as known overdose cases. Therefore the presence of 149 
any drug must not be interpreted as being implicated in the cause of death.  150 
2.3 Sample Treatment 151 
2.3.1 Wastewater 152 
Sample preparation and solid phase extraction (SPE) were performed as in our previous 153 
work. 
23
  Briefly, samples were warmed to room temperature then filtered under vacuum 154 
using glass microfibre filters GF/A 1.6 µm (Whatman, Kent, U.K.). The deuterated internal 155 
standards (200 μL) were then spiked into 200 mL sample. 10% Acetic acid was added to 156 
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lower the pH (4.5-5) of the samples. The acidified samples were loaded onto mixed-mode 157 
SPE cartridges (UCT XRDAH (UCT Inc., Bristol, PA, USA); 500 mg/6 mL) which had been 158 
conditioned with methanol (6 mL) and sodium acetate buffer (20 mM pH 5, 6 mL). The 159 
cartridges were successively washed with sodium acetate buffer (6 mL), 0.1 M acetic acid (2 160 
mL) and methanol (6 mL). Analytes were eluted with a mixture of 161 
dichloromethane:isopropanol:ammonia (80:16:4) and evaporated to 200 µL under nitrogen at 162 
40°C, when 1% HCl in methanol was added, then evaporated to dryness. The dry residue was 163 
reconstituted with 0.1% formic acid in methanol (20 µL) and 0.1% formic acid in milliQ 164 
water (180 µL). Analyses were performed by injecting 10 µL in the LC-QTOF-MS and 3µL 165 
in the UHPLC-QqQ-MS. The pre-concentration factor along sample treatment was x1000 166 
(200 mL sample to a final extract volume of 200 µL). 167 
2.3.2 Post Mortem Blood Samples  168 
Sample preparation was performed as previously described. 
24
 Briefly, an aliquot of whole 169 
blood (500 μL) was mixed with distilled water (1.5 mL), mixed internal standard solution (25 170 
μL), concentrated ammonia solution (250 μL) and butyl chloride (5 mL). The blood was 171 
agitated on a rotating extractor at 80 rpm for 10 min and centrifuged at 3,000 rpm for 15 min. 172 
The supernatant was decanted and evaporated to dryness in a centrifugal evaporator 173 
(GeneVac EZ2 plus, Scitek, Melbourne, Australia). The residue was reconstituted in 100 μL 174 
ethanol.  175 
2.4 Instrumentation 176 
All liquid chromatography-mass spectrometry parameters can be found in the supporting 177 
information.  178 
2.5 Criteria for Qualitative and Quantitative Analysis  179 
The criteria used for the identification of compounds in wastewater in this study were similar 180 
to those devised by Hernandez et al. and Schymanski et al.
25,26
 as outlined below. In the 181 
Forensic toxicology samples, mass spectrometry identification met criteria for Australian and 182 
New Zealand Forensic Toxicology laboratories. 
27
 The identification of NPS in forensic 183 
samples was assisted by supporting intelligence from local and interstate NPS seizures, case 184 
notes, and the examination of drugs and paraphernalia from the scene of death. 185 
2.5.1 QTOF Screening  186 
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Compounds in wastewater and post mortem blood samples were detected using one accurate 187 
mass ion (mass error ± 2 mDa) and retention time agreement with a reference standard (± 188 
2%). Confirmation of the identity of the compound detected involved at least two accurate 189 
mass ions (± 2 mDa), with one of which preferably being the protonated molecule, and 190 
agreement of retention time and isotopic pattern with a reference standard (± 2%). Tentative 191 
identification was made in those cases when the reference standard was not available at the 192 
laboratory. It was based on the presence of at least two accurate mass ions (mass error ± 2 193 
mDa), supported by literature mass data on the suspect compound.  194 
2.5.2 QqQ Quantification 195 
The wastewater sample treatment indicated in Section 2.3.1 was optimized and validated in 196 
20
. It was applied at the University of South Australia (Australia). The SPE eluates were 197 
shipped to Spain and analyzed at the University Jaume I of Castellon (Spain), applying the 198 
instrumental conditions reported in the supporting information and 
19
. At least two transitions 199 
were monitored for each compound, one quantification transitions (Q) and two confirmation 200 
transitions (q1 and q2), except for methedrone for which only two transitions could be 201 
selected. For positive confirmation, the following criteria were applied: retention time 202 
compatibility with the standard (± 2 %), and ion ratio (q/Q) deviation within ± 30% for at 203 
least one confirmation transition in comparison with the reference standard.  204 
3. Results and Discussion 205 
3.1 Database for Qualitative Screening Analysis 206 
A database including 85 NPS reference standards of FSSA and exact mass information of an 207 
additional 101 NPS was used in this work and are shown in Table S1. The selection of NPS 208 
standards was based on detection by FSSA’s illicit drug laboratory, police and interstate 209 
forensic laboratories intelligence as well as media and literature (such as the EMCDDA early 210 
warning system and the Australian National Drug and Alcohol Research Centre bulletin of 211 
drugs and the internet 
28
). This was a compromise between exhaustive NPS coverage and 212 
finite resources, but, encapsulated a significant number of NPS likely to be encountered in 213 
South Australia. 
24
  214 
3.2 Suspect Compound Screening of New Psychoactive Substances by QTOF-MS 215 
HRMS suspect compound screening is becoming the technique of choice for forensic 216 
toxicology centres to detect and confirm NPS in various biological matrices, using databases 217 
Page 9 of 21 
 
similar to that described above. The value of qualitative HRMS screening is supported by the 218 
fact that some forensic science experts have even questioned the value of quantitative 219 
analysis of NPS, since the toxicology and metabolism of many of the compounds are 220 
unknown. 
29
 In this context, WWA is a complementary source of information on population-221 
scale drug use. 222 
Figures 1a and b show the qualitative temporal comparison between the toxicological data 223 
(post mortem blood samples) and wastewater data from June 2012 – June 2017. The colours 224 
represent the means of identification: wastewater analysis (blue), toxicological data (orange) 225 
and both (green). Confirmation of the identity was possible for all compounds shown in 226 
Figure 1, while 25H-NBOMe was detected, but not fully confirmed in wastewater according 227 
to the criteria outlined in Section 2.5.1, and pentylone could only be tentatively identified in 228 
wastewater due to the lack of a reference standard at the laboratory. In total, 18 NPS were 229 
found in the forensic samples, 11 in wastewater and five in both. 230 
All wastewater samples were screened by applying a three-step workflow using MasterView. 231 
The first step assumed that no standard was available and contained just the exact mass of the 232 
NPS. On average, 140 compounds could be excluded from the initial database of 186 233 
compounds. All substances found within the aforementioned mass threshold of 2 mDa were 234 
then screened employing the second step, which included retention times of all NPS for 235 
which reference standards were available to get a list of “detected” compounds (described in 236 
Section 2.5.1). This further reduced the number of compounds down to 11.  Finally, step 3 237 
involved confirmation of the identity of all “detected” compounds by using information of 238 
fragment ions (“confirmation” in section 2.5.1), to give the results shown in Figure 1. 239 
Therefore, this three-step workflow shows the risk of finding false positives in the absence of 240 
reference standards.  241 
Since 2008, synthetic cathinones have accounted for the highest proportion of NPS seizures 242 
in Australia. 
30
 The cathinones mephedrone and methylone have been monitored in Australia 243 
as part of the National Wastewater Drug Monitoring Program. Both were usually detected 244 
below the limit of reporting with detections decreasing over the monitoring program. 
31
  They 245 
were also the most common family of NPS found in wastewater and early toxicological 246 
samples included in this study. Between August 2015 and December 2016, fentanyl 247 
derivatives were more commonly identified in toxicological samples. Alpha PVP was the 248 
compound most commonly found in both sources, in June 2014 and from February 2015 – 249 
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August 2015. Synthetic cathinones and piperazines were predominantly reported in 250 
wastewater samples, while only phenethylamines, cannabinoids and fentanyl derivatives were 251 
found in toxicological samples. These latter NPS families are typically very low dose 252 
compounds i.e. low µg, and are often difficult to detect even in blood samples. This rendered 253 
them unlikely to be detected in wastewater unless they had widespread use, while synthetic 254 
cannabinoids are notoriously difficult to find in wastewater due to their extensive metabolism 255 
17
 and requiring the need for specific sample treatment. 
32
 256 
From the wastewater data, a trend in the use of synthetic cathinones is visible. Methylone was 257 
prevalent from 2013-mid 2014, then disappeared. At this point, ethylone entered the scene 258 
until early 2017, with pentylone tentatively identified in more recent 2017 samples. The 259 
cathinones ethylone, alpha-PVP and mephedrone, as well as TFMPP were in common with 260 
the forensic toxicology samples. Since a number of NPS were found using the qualitative 261 
wastewater and forensic data, quantitative analysis of the relevant samples were conducted to 262 
determine their prevalence in wastewater.  263 
3.3 Quantitative Results 264 
Quantitative analysis in WWA can demonstrate the scale and prevalence of use. Based on a 265 
previously validated method, a selection of weekend samples from April 2015 – August 2017 266 
were quantitatively analysed. 
19
 A further 13 NPS were added to the method (Table S3), due 267 
to them being found in the QTOF screening method, with quantification based on the criteria 268 
outlined in Section 2.5.2. In total, the number of target analytes included in the LC-MS/MS 269 
method was 20. The quantitative method was not fully validated for the 13 additional NPS 270 
but was based on their validated structural analogues. Therefore, for these compounds 271 
concentration data should be considered as semi-quantitative. For quantitative analysis, a 272 
calibration standard curve (1 – 20 ng/L) was injected in duplicate.  The limit of quantification 273 
(LOQ) and limit of detection (LOD) were estimated directly from positively detected samples 274 
where the compound had a signal to noise of >10 (LOQ) or >3 (LOD). Information on LOD 275 
and LOQ is presented in Table S4.  276 
Seven NPS were detected and quantified in total across all samples. Using concentration data 277 
(ng/L), the daily mass loads were estimated making use of the wastewater flow rates and 278 
population (Table 1). Details of these parameters are given in Table S5 and calculations 279 
performed are the same as in 
20
. The population figure was kept constant in spite of the 280 
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different years of the samples as the greater Adelaide region has had a population growth of 281 
1% per year from 2011-2017, which we deem minimal. 282 
There are some distinct patterns in NPS use visible in Table 1. Methcathinone was detected 283 
at a relatively constant concentration in all samples.  Alpha-PVP and mephedrone were only 284 
detected in the 2015 samples, which mirrors the screening data (Figures 1a and b).  Ethylone 285 
was detected in every sample. However, it decreased in use from 2015-2017. It is interesting 286 
to note that butylone started to be detected as ethylone started to decline (Figure 2). As both 287 
compounds have the same transitions (222.1 > 174, 222.1 > 146 and 222.1 > 131.2), it was 288 
easy to monitor their changes from the common chromatograms, as shown in Figure 2. The 289 
97% decline in ethylone use coincided with a 200% increase in butylone, based on peak area. 290 
In a previous study, we showed that methylone disappeared from South Australia WWA in 291 
2014. 
20
 This is similar to what was seen in South East Queensland, where there was a peak in 292 
use  of methylone  in 2012-2013.
33
 It was thus interesting to note the rise in ethylone 293 
subsequent to 2014, which matched the observations in the qualitative method. Another 294 
synthetic cathinone, pentylone, was detected intermittently, but at a higher concentration in 295 
more recent samples. It will be of interest to see whether these cathinones will continue to be 296 
seen in future samples.  297 
3.4 Complementarity of forensic and wastewater data 298 
In this study, forensic data confirmed the presence of 18 NPS in post mortem specimens. 299 
Such deaths represent a small subset of the drug user population which provides a source of 300 
intelligence regarding the presence of NPS. The detection of NPS in the post-mortem samples 301 
is determined by several factors. These include the consumption of a substance leading up to 302 
the death when it is still detectable in blood, even if the compound was not the cause of death. 303 
When a NPS is taken by a sub-population, it may thus not appear in any forensic toxicology 304 
post mortems.  305 
WWA is a complementary tool and can be considered as a diluted pooled urine sample, 306 
allowing the measurement and estimation of a drug that is consumed in a community. In this 307 
study, it was used to indicate the presence of 11 NPS. Due to dilution effects and low 308 
excretion rates, infrequently used NPS may not be found in wastewater. In addition, the 309 
metabolism of some NPS remains unknown and therefore a method targeting the parent drug 310 
may not find the drug in wastewater. As pharmacokinetic information becomes available, this 311 
limitation may be overcome. In addition to detecting community use of a NPS, WWA can 312 
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show the scale of use. Since there will always only be partial overlap between the two 313 
datasets, this work emphasises the complementarity of these sources.   314 
Conclusion 315 
A temporal investigation into NPS use in South Australia from 2012 – 2017 has been done 316 
utilising both post mortem forensic and wastewater data. A total of 24 NPS were found: six in 317 
wastewater only, 13 in forensic post mortem toxicology samples only and five in both. 318 
Synthetic cathinones were most prevalent, with an interesting temporal pattern of use. 319 
Methylone was used in the early years, followed by ethylone, while in more recent samples 320 
butylone and pentylone were found. The study showed that by combining forensic and 321 
wastewater data, it increased the likelihood of detecting NPS use in a community. This work 322 
highlights the value and complementary nature of WWA and forensic data in evaluating the 323 
total use of NPS. 324 
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Figure Captions 439 
Figure 1a: NPS found from QTOF screening of wastewater and forensic toxicological 440 
samples from June 2012 - December 2014. Dark blue indicates that the NPS was confirmed 441 
in wastewater, orange indicates the NPS was confirmed in forensic toxicological samples and 442 
green indicates the NPS was confirmed in both.  443 
Abbreviations: Alpha-PVP (α-pyrrolidinopentiophenone); MDPV 444 
(methylenedioxypyrovalerone); 5-APB (5-(2-aminopropyl)benzofuran); 5-EAFB (1-445 
(benzofuran-5-yl)-N-ethylpropan-2-amine); BZP (benzylpiperazine); TFMPP (3-446 
trifluoromethylphenylpiperazine); MDA (3,4-methylenedioxyamphetamine)  447 
 448 
Figure 1b: NPS found from QTOF screening of wastewater and forensic toxicological 449 
samples from February 2015 – June 2017. Dark blue indicates that the NPS was confirmed in 450 
wastewater, orange indicates the NPS was confirmed in forensic toxicological samples and 451 
green indicates the NPS was confirmed in both.  452 
*compound only detected in wastewater; 
a
tentatively identified as no reference standard was 453 
available. 454 
Abbreviations: Alpha-PVP (α-pyrrolidinopentiophenone); MDPV 455 
(methylenedioxypyrovalerone); 5-APB (5-(2-aminopropyl)benzofuran); 5-EAFB (1-456 
(benzofuran-5-yl)-N-ethylpropan-2-amine); BZP (benzylpiperazine); TFMPP (3-457 
trifluoromethylphenylpiperazine); MDA (3,4-methylenedioxyamphetamine) 458 
Figure 2: Detection of ethylone (2.54) and butylone (2.73) from April 2015, August 2016 459 
and August 2017. Both ethylone and butylone have the same transitions: 222.1 > 164 (TOP), 460 
222.1 > 146 (MIDDLE) and 222.1 > 131.2 (BOTTOM).  461 
  462 
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Tables 463 
Table 1: Average weekend (i.e. Saturday and Sunday) excreted mass loads of NPS found using the quantitative 464 
method (mg/day/1000 people) 465 
 Butylone  Ethylone Alpha 
PVP 
Methcathinone MDPV Pentylone Mephedrone 
Apr 15 A   0.96 0.04 0.32 D  D 
Apr 15 B   0.70 0.05 0.29  D  
Aug 16 A   0.65  0.43    
Aug 16 B   0.22 0.05 0.67  D  
Feb 17 A   0.23  0.38  D  
Feb 17 B   0.13  0.32    
Jun 17 A   0.35  0.21  0.12  
Jun 17 B   0.29  0.30  D  
Aug 17 A  D 0.13  0.51  D  
Aug 17 B  D 0.12  0.46    
D = below LOQ 466 
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